Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

OncoGenex Pharmaceuticals Company Profile (NASDAQ:OGXI)

Consensus Ratings for OncoGenex Pharmaceuticals (NASDAQ:OGXI) (?)
Ratings Breakdown: 5 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.17)
Consensus Price Target: $21.15 (104.94% upside)

Analysts' Ratings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/27/2014CRT CapitalInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Stifel NicolausLower Price TargetBuy$26.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
10/28/2013Needham & Company LLCUpgradeBuy -> Strong-Buy$20.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Stifel NicolausLower Price TargetBuy$30.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
7/3/2013ZacksUpgradeNeutral -> Outperform$11.90ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013RBC CapitalBoost Price TargetOutperform$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
5/3/2013Bloom BurtonBoost Price TargetBuy$20.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Bloom BurtonBoost Price Target$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
8/3/2012Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/18/2012Needham & Company LLCInitiated CoverageBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
5/4/2012Bloom BurtonLower Price TargetBuy$19.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/18/2012 forward)